Brighton House Q1 2024 Update

It was a busy first quarter of 2024 at Brighton House. Despite the very challenging fundraising market, we successfully advised on several fund closings. We also expanded our secondary advisory capabilities driven by continued demand from our network of capital providers for both LP and GP-led opportunities. Below are a few highlights:

HealthpointCapital closes MSK Fund II

Based in San Diego and New York, HealthpointCapital is a private equity firm with a twenty-year history investing in leading healthcare companies across company lifecyles. The MSK Fund II is the firm’s second fund focused on acquiring high-growth medical device companies.

We would like to congratulate Mike Mogul and the entire team at HealthpointCapital on the successful raise and look forward to a long-term partnership in the years to come.

RevolverCap closes second private credit fund

Brighton House was the sole advisor to RevolverCap on the raise of Fund II. Based in New York, RevolverCap is a specialized private credit manager which invests in senior-secured revolving lines of credit. New limited partners who joined the fund included Institutional and Family Office investors in North America and Internationally.

Investors seeking GP-led secondary opportunities

We are actively advising on single and multi-asset continuation vehicles due to increasing demand from our network of institutional and family office investors. The opportunities being requested include:

• Transaction Sizes: $25m - $250m

• Asset Types: Mature, cash flowing companies

• Regions: North America and Europe

Please email Dan McDermott, dm@bhafunds.com, if you would like to discuss Brighton House’s advisory services across primary, secondary, or direct co-investments.